These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 9000260

  • 21. Gastrin receptor antagonist YM022 prevents hypersecretion after long-term acid suppression.
    Nishida A, Kobayashi-Uchida A, Akuzawa S, Takinami Y, Shishido T, Kamato T, Ito H, Yamano M, Yuki H, Nagakura Y.
    Am J Physiol; 1995 Nov; 269(5 Pt 1):G699-705. PubMed ID: 7491961
    [Abstract] [Full Text] [Related]

  • 22. Role of gastrin and cholecystokinin receptors in regulation of peptone-stimulated gastric acid secretion in conscious rats.
    Varga G, Campbell DR, Bussjaeger LJ, Solomon TE.
    Eur J Pharmacol; 1993 Nov 30; 250(1):37-42. PubMed ID: 8119323
    [Abstract] [Full Text] [Related]

  • 23. Mobilization of rat stomach ECL-cell histamine in response to short- or long-term treatment with omeprazole and/or YF 476 studied by gastric submucosal microdialysis in conscious rats.
    Konagaya T, Bernsand M, Norlén P, Håkanson R.
    Br J Pharmacol; 2001 May 30; 133(1):37-42. PubMed ID: 11325792
    [Abstract] [Full Text] [Related]

  • 24. The effect of CCKB/gastrin antagonists on stimulated gastric acid secretion in the anaesthetized rat.
    Hayward NJ, Harding M, Lloyd SA, McKnight AT, Hughes J, Woodruff GN.
    Br J Pharmacol; 1991 Dec 30; 104(4):973-7. PubMed ID: 1687371
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of gastrin- and histamine-stimulated gastric acid secretion by gastrin and cholecystokinin antagonists in the rat.
    Hirst BH, Elliott KJ, Ryder H, Szelke M.
    Aliment Pharmacol Ther; 1991 Feb 30; 5(1):31-9. PubMed ID: 1932479
    [Abstract] [Full Text] [Related]

  • 26. Selective inhibition of pentagastrin- and cholecystokinin-stimulated exocrine secretion by proglumide.
    Loewe CJ, Grider JR, Gardiner J, Vlahcevic ZR.
    Gastroenterology; 1985 Oct 30; 89(4):746-51. PubMed ID: 2863192
    [Abstract] [Full Text] [Related]

  • 27. Gastric submucosal microdialysis: a method to study gastrin- and food-evoked mobilization of ECL-cell histamine in conscious rats.
    Kitano M, Norlén P, Håkanson R.
    Regul Pept; 2000 Jan 29; 86(1-3):113-23. PubMed ID: 10672910
    [Abstract] [Full Text] [Related]

  • 28. Reversibility of cholecystokinin-B/gastrin receptor blockade: a study of the gastrin-ECL cell axis in the rat.
    Norlén P, Lindström E, Ding XQ, Kitano M, Håkanson R.
    Pharmacol Toxicol; 1999 Apr 29; 84(4):159-64. PubMed ID: 10227066
    [Abstract] [Full Text] [Related]

  • 29. Gastric acid secretion in L-histidine decarboxylase-deficient mice.
    Tanaka S, Hamada K, Yamada N, Sugita Y, Tonai S, Hunyady B, Palkovits M, Falus A, Watanabe T, Okabe S, Ohtsu H, Ichikawa A, Nagy A.
    Gastroenterology; 2002 Jan 29; 122(1):145-55. PubMed ID: 11781289
    [Abstract] [Full Text] [Related]

  • 30. Cholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the rat.
    Schmassmann A, Garner A, Flogerzi B, Hasan MY, Sanner M, Varga L, Halter F.
    Gut; 1994 Feb 29; 35(2):270-4. PubMed ID: 8307482
    [Abstract] [Full Text] [Related]

  • 31. Augmentation of the inhibitory effect of FK480, a CCK-A receptor antagonist, on pancreatic exocrine secretion by achlorhydria.
    Kuno M, Sogabe H, Ito H, Matsuo T, Satoh Y, Motoyama Y, Tanaka H.
    Pancreas; 1998 Jul 29; 17(1):57-64. PubMed ID: 9667521
    [Abstract] [Full Text] [Related]

  • 32. (3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist.
    Semple G, Ryder H, Rooker DP, Batt AR, Kendrick DA, Szelke M, Ohta M, Satoh M, Nishida A, Akuzawa S, Miyata K.
    J Med Chem; 1997 Jan 31; 40(3):331-41. PubMed ID: 9022799
    [Abstract] [Full Text] [Related]

  • 33. Effects of S-0509, a novel CCKB/gastrin receptor antagonist, on acid secretion and experimental duodenal ulcers in rats.
    Takeuchi K, Hirata T, Yamamoto H, Kunikata T, Ishikawa M, Ishihara Y.
    Aliment Pharmacol Ther; 1999 Jan 31; 13(1):87-96. PubMed ID: 9892884
    [Abstract] [Full Text] [Related]

  • 34. [Gastrin/CCK-B receptor antagonists for a novel antiulcer agent].
    Miyata K, Nishida A, Honda K.
    Nihon Yakurigaku Zasshi; 1995 Sep 31; 106(3):171-80. PubMed ID: 8529962
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effect of cholecystokinin-2 receptor blockade on rat stomach ECL cells. A histochemical, electron-microscopic and chemical study.
    Chen D, Zhao CM, Norlén P, Björkqvist M, Ding XQ, Kitano M, Håkanson R.
    Cell Tissue Res; 2000 Jan 31; 299(1):81-95. PubMed ID: 10654072
    [Abstract] [Full Text] [Related]

  • 37. CCK-B (gastrin) receptor regulates gastric histamine release and acid secretion.
    Sandvik AK, Waldum HL.
    Am J Physiol; 1991 Jun 31; 260(6 Pt 1):G925-8. PubMed ID: 1711780
    [Abstract] [Full Text] [Related]

  • 38. Effect of cholecystokinin receptor antagonists, MK-329 and L-365,260, on cholecystokinin-induced acid secretion and histidine decarboxylase activity in the rat.
    Kawabata S, Kanayama S, Shinomura Y, Miyazaki Y, Imamura I, Moriwaki K, Wada H, Tarui S.
    Regul Pept; 1991 Jul 23; 35(1):1-10. PubMed ID: 1924892
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. New 1,4-benzodiazepin-2-one derivatives as gastrin/cholecystokinin-B antagonists.
    Satoh M, Kondoh Y, Okamoto Y, Nishida A, Miyata K, Ohta M, Mase T, Murase K.
    Chem Pharm Bull (Tokyo); 1995 Dec 23; 43(12):2159-67. PubMed ID: 8582018
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.